Kremer Hovinga, Johanna A

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 40.

Journal Article

Larsen, Emil List; Nilius, Henning; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Greinacher, Andreas; Mendez, Adriana; Schmidt, Adrian; Wuillemin, Walter A; Gerber, Bernhard; Vishnu, Prakash; Graf, Lukas; Kremer Hovinga, Johanna A; Goetze, Jens P; Bakchoul, Tamam; Nagler, Michael (2024). Accuracy of Diagnosing Heparin-Induced Thrombocytopenia. JAMA Network Open, 7(3) American Medical Association 10.1001/jamanetworkopen.2024.3786

Schimmer, Roman R; Sutter, Tabea; Bachofner, Adrian; Ranieri, Elisabetta; Rodewald, Ann-Kathrin; Kremer Hovinga, Johanna A; Kimmich, Nina; Trinchero, Alice; Studt, Jan-Dirk (2024). Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab. (In Press). British journal of haematology Wiley-Blackwell 10.1111/bjh.19284

Castaman, Giancarlo; Peyvandi, Flora; Kremer Hovinga, Johanna A; Schutgens, Roger E G; Robson, Susan; Moreno, Katya; Jiménez-Yuste, Víctor (2024). Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors. TH open, 8(1), e42-e54. Thieme 10.1055/s-0043-1777766

Scutelnic, Adrian; van de Munckhof, Anita; Krzywicka, Katarzyna; van Kammen, Mayte Sánchez; Lindgren, Erik; Cordonnier, Charlotte; Kleinig, Timothy J; Field, Thalia S; Poli, Sven; Lemmens, Robin; Middeldorp, Saskia; Aaron, Sanjith; Borhani-Haghighi, Afshin; Arauz, Antonio; Kremer Hovinga, Johanna A; Günther, Albrecht; Putaala, Jukka; Wasay, Mohammad; Conforto, Adriana Bastos; de Sousa, Diana Aguiar; ... (2023). Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19. European stroke journal, 8(4), pp. 1001-1010. Sage 10.1177/23969873231185213

Barton, J Cameron; Anderson, Cooper; Miranda, Frida Z; Kelley, Rachel; Kremer Hovinga, Johanna A; Terrell, Deirdra; Vesely, Sara K; George, James N; Muia, Joshua (2023). Cattle-FRETS71, a Novel Fluorogenic Substrate with Broad Applicability for Characterizing ADAMTS13 Properties and Function. Journal of thrombosis and haemostasis, 21(12), pp. 3393-3401. Wiley-Blackwell 10.1016/j.jtha.2023.08.016

Hammerer-Lercher, Angelika; Nilius, Henning; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Greinacher, Andreas; Mendez, Adriana; Schmidt, Adrian; Wuillemin, Walter A; Gerber, Bernhard; Kremer Hovinga, Johanna A; Vishnu, Prakash; Graf, Lukas; Bakchoul, Tamam; Nagler, Michael (2023). Limited concordance of heparin/PF4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study. Journal of thrombosis and haemostasis, 21(9), pp. 2559-2568. Wiley-Blackwell 10.1016/j.jtha.2023.05.016

Miesbach, Wolfgang; Oldenburg, Johannes; Klamroth, Robert; Eichler, Hermann; Koscielny, Jürgen; Holzhauer, Susanne; Holstein, Katharina; Kremer Hovinga, Johanna A; Alberio, Lorenzo; Olivieri, Martin; Knöfler, Ralf; Male, Christoph; Tiede, Andreas (2023). Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH). Hämostaseologie, 43(3), pp. 196-207. Thieme 10.1055/a-1957-4477

Ruberti, Andrea Alberto; Kremer Hovinga, Johanna A; Federico, Nappi; Aurora, Vettese; Elena, Bianchi; Eliana, Fernandes; Elena, Galfetti; Rita, Monotti; Pamella, Paul; Stefano, Regazzoni; Daniela, Valente; Davide, Rossi; Georg, Stussi; Bernhard, Gerber (2023). Acquired haemophilia A in southern Switzerland from 2013 to 2019: a case series. Swiss medical weekly, 153, p. 40048. EMH Schweizerischer Ärzteverlag 10.57187/smw.2023.40048

Asmis, Lars M; Serra, Andreas; Krafft, Alexander; Licht, Abraham; Leisinger, Elke; Henschkowski-Serra, Jana; Ganter, Michael T; Hauptmann, Steffen; Tinguely, Marianne; Kremer Hovinga, Johanna A (2022). Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura. The New England journal of medicine, 387(25), pp. 2356-2361. Massachusetts Medical Society 10.1056/NEJMoa2211113

Scully, Marie; de la Rubia, Javier; Pavenski, Katerina; Metjian, Ara; Knöbl, Paul; Peyvandi, Flora; Cataland, Spero; Coppo, Paul; Kremer Hovinga, Johanna A; Minkue Mi Edou, Jessica; De Passos Sousa, Rui; Callewaert, Filip; Gunawardena, Sriya; Lin, Julie (2022). Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study. Journal of thrombosis and haemostasis, 20(12), pp. 2810-2822. Wiley-Blackwell 10.1111/jth.15892

Scutelnic, Adrian; Krzywicka, Katarzyna; Mbroh, Joshua; van de Munckhof, Anita; Sánchez van Kammen, Mayte; Aguiar de Sousa, Diana; Lindgren, Erik; Jood, Katarina; Günther, Albrecht; Hiltunen, Sini; Putaala, Jukka; Tiede, Andreas; Maier, Frank; Kern, Rolf; Bartsch, Thorsten; Althaus, Katharina; Ciccone, Alfonso; Wiedmann, Markus; Skjelland, Mona; Medina, Antonio; ... (2022). Management of cerebral venous thrombosis due to adenoviral COVID-19 vaccination. Annals of neurology, 92(4), pp. 562-573. Wiley-Blackwell 10.1002/ana.26431

van de Munckhof, Anita; Lindgren, Erik; Kleinig, Timothy J; Field, Thalia S; Cordonnier, Charlotte; Krzywicka, Katarzyna; Poli, Sven; Sánchez van Kammen, Mayte; Borhani-Haghighi, Afshin; Lemmens, Robin; Scutelnic, Adrian; Ciccone, Alfonso; Gattringer, Thomas; Wittstock, Matthias; Dizonno, Vanessa; Devroye, Annemie; Elkady, Ahmed; Günther, Albrecht; Cervera, Alvaro; Mengel, Annerose; ... (2022). Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase. Stroke, 53(10), pp. 3206-3210. Lippincott Williams & Wilkins 10.1161/STROKEAHA.122.039575

Draxler, Domink F; Brodard, Justine; Zante, Björn; Jakob, Stephan M; Wiegand, Jan; Kremer Hovinga, Johanna A; Angelillo-Scherrer, Anne; Rovo, Alicia (2022). The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia. Thrombosis journal, 20(1), p. 55. BioMed Central 10.1186/s12959-022-00411-0

Borogovac, Azra; Tarasco, Erika; Kremer Hovinga, Johanna A; Friedman, Kenneth D; Asch, Adam S; Vesely, Sara K; Prodan, Calin; Terrell, Deirdra R; George, James N (2022). Prevalence of Neuropsychiatric Symptoms and Stroke in Patients with Hereditary Thrombotic Thrombocytopenic Purpura. Blood, 140(7), pp. 785-789. American Society of Hematology 10.1182/blood.2022016044

Heeb, Silvan R; Schaller Tschan, Monica Maria; Kremer Hovinga, Johanna A (2022). Naturally Occurring Anti-Idiotypic Antibodies Portray a Largely Private Repertoire in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Journal of immunology, 208(11), pp. 2497-2507. American Association of Immunologists 10.4049/jimmunol.2100868

Buetler, Vanessa Alexandra; Agbariah, Nada; Schild, Deborah Pia; Liechti, Fabian D; Wieland, Anna; Andina, Nicola; Hammann, Felix; Kremer Hovinga, Johanna A (2022). Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature. Frontiers in medicine, 9, p. 890661. Frontiers 10.3389/fmed.2022.890661

Krzywicka, Katarzyna; van de Munckhof, Anita; Sánchez van Kammen, Mayte; Heldner, Mirjam R; Jood, Katarina; Lindgren, Erik; Tatlisumak, Turgut; Putaala, Jukka; Kremer Hovinga, Johanna A; Middeldorp, Saskia; Levi, Marcel M; Cordonnier, Charlotte; Arnold, Marcel; Zwinderman, Aeilko H; Ferro, José M; Coutinho, Jonathan M; Aguiar de Sousa, Diana (2022). Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination. Neurology, 98(7), e759-e768. American Academy of Neurology 10.1212/WNL.0000000000013148

Scutelnic, Adrian; Brodard, Justine; Kremer Hovinga, Johanna A; Arnold, Marcel; Heldner, Mirjam R (2022). Cerebral Venous Sinus Thrombosis Associated with Vaccine-Induced Thrombotic Thrombocytopenia—A Narrative Review. Clinical and translational neuroscience, 6(2), p. 11. MDPI 10.3390/ctn6020011

Tarasco, Erika; Bütikofer, Lukas; Friedman, Kenneth D; George, James N; Hrachovinova, Ingrid V; Knöbl, Paul; Matsumoto, Masanori; von Krogh, Anne Sophie; Aebi-Huber, Isabella; Cermakova, Zuzana; Górska-Kosicka, Magdalena; Jalowiec, Katarzyna A; Largiadèr, Carlo R; Prohaszka, Zoltan; Sinkovits, György; Windyga, Jerzy; Lämmle, Bernhard; Kremer Hovinga, Johanna A (2021). Annual Incidence and Severity of Acute Episodes in Hereditary Thrombotic Thrombocytopenic Purpura. Blood, 137(25), pp. 3563-3575. American Society of Hematology 10.1182/blood.2020009801

Du, Vivian X; van Os, Gwen; Kremer Hovinga, Johanna A; Dienava-Verdoold, Ilze; Wollersheim, Jacques; Ruggeri, Zaverio M; Fijnheer, Rob; de Groot, Philip G; de Laat, Bas (2012). Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura. British journal of haematology, 159(1), pp. 94-103. Oxford: Wiley-Blackwell 10.1111/bjh.12004

Fuchs, Tobias A; Kremer Hovinga, Johanna A; Schatzberg, Daphne; Wagner, Denisa D; Lämmle, Bernhard (2012). Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood, 120(6), pp. 1157-64. Washington, D.C.: American Society of Hematology 10.1182/blood-2012-02-412197

Kremer Hovinga, Johanna A; Voorberg, Jan (2012). Improving on nature: redesigning ADAMTS13. Blood, 119(16), pp. 3654-5. Washington, D.C.: American Society of Hematology 10.1182/blood-2012-02-410431

Som, Sumit; Deford, Cassandra C; Kaiser, Mandi L; Terrell, Deirdra R; Kremer Hovinga, Johanna A; Lämmle, Bernhard; George, James N; Vesely, Sara K (2012). Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion, 52(12), 2525-32; quiz 2524. Malden, Mass.: Wiley-Blackwell 10.1046/j.1537-2995.2000.40080896.x

George, James N; Terrell, Deirdra R; Vesely, Sara K; Kremer Hovinga, Johanna A; Lämmle, Bernhard (2012). Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse médicale, 41(3 Pt 2), e177-88. Issy-les-Moulineaux (F): Elsevier Masson SAS 10.1016/j.lpm.2011.10.026

Kremer Hovinga, Johanna A; Lämmle, Bernhard (2012). Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. Hematology, 2012, pp. 610-616. Washington, D.C.: American Society of Hematology 10.1182/asheducation-2012.1.610

Froehlich-Zahnd, Rahel; George, James N; Vesely, Sara K; Terrell, Deirdra R; Aboulfatova, Khatira; Dong, Jing-Fei; Luken, Brenda M; Voorberg, Jan; Budde, Ulrich; Sulzer, Irmela; Lämmle, Bernhard; Kremer Hovinga, Johanna A (2011). Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica - the hematology journal, 97(2), pp. 297-303. Pavia: Ferrata-Storti Foundation

Jahns, Maximilian; Friess, Dorothea; Demarmels Biasiutti, Franziska; Kremer Hovinga, Johanna A; Alberio, Lorenzo; Oldenburg, Johannes; Lämmle, Bernhard; Colucci, Giuseppe (2011). Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: another case of factor IX propeptide mutation. Thrombosis and haemostasis, 106(2), pp. 381-2. Stuttgart: Schattauer 10.1160/TH11-03-0191

Terrell, Deirdra R; Motto, David G; Kremer Hovinga, Johanna A; Lämmle, Bernhard; George, James N; Vesely, Sara K (2011). Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion, 51(10), pp. 2237-43. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2011.03125.x

Cataland, Spero R; Peyvandi, Flora; Mannucci, Pier M; Lämmle, Bernhard; Kremer Hovinga, Johanna A; Machin, Samuel J; Scully, Marie; Rock, Gail; Gilbert, James C; Yang, Shangbin; Wu, Haifeng; Jilma, Bernd; Knoebl, Paul (2011). Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura. American journal of hematology, 87(4), pp. 430-2. New York, N.Y.: Wiley-Liss 10.1002/ajh.23106

Benjamin, Melody; Terrell, Deirdra R; Vesely, Sara K; Voskuhl, Gene W; Dezube, Bruce J; Kremer Hovinga, Johanna A; Lämmle, Bernhard; George, James N (2009). Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clinical infectious diseases, 48(8), pp. 1129-37. Cary, N.C.: The University of Chicago Press 10.1086/597471

Kennedy, April S; Lewis, Qurana F; Scott, James G; Kremer Hovinga, Johanna A; Lämmle, Bernhard; Terrell, Deirdra R; Vesely, Sara K; George, James N (2009). Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion, 49(6), pp. 1092-101. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2009.02101.x

Swisher, Karen K; Terrell, Deirdra R; Vesely, Sara K; Kremer Hovinga, Johanna A; Lämmle, Bernhard; George, James N (2009). Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion, 49(5), pp. 873-87. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2008.02082.x

Karpac, Charity A; Li, Xiaoning; Terrell, Deirdra R; Kremer Hovinga, Johanna A; Lämmle, Bernhard; Vesely, Sara K; George, James N (2008). Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. British journal of haematology, 141(5), pp. 696-707. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2008.07116.x

Lämmle, Bernhard; Kremer Hovinga, Johanna A; George, James N (2008). Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease. Haematologica - the hematology journal, 93(2), pp. 172-7. Pavia: Ferrata-Storti Foundation 10.3324/haemato.12701

Meyer, Sara C; Jeddi, Ramzi; Meddeb, Balkis; Gouider, Emna; Lämmle, Bernhard; Kremer Hovinga, Johanna A (2008). A first case of congenital TTP on the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13. Annals of hematology, 87(8), pp. 663-6. Berlin: Springer 10.1007/s00277-008-0496-6

George, James N; Kremer Hovinga, Johanna A; Terrell, Deirdra R; Vesely, Sara K; Lämmle, Bernhard (2008). The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. European journal of haematology, 80(4), pp. 277-86. Oxford: Wiley-Blackwell 10.1111/j.1600-0609.2008.01040.x

Kremer Hovinga, Johanna A; Meyer, Sara C (2008). Current management of thrombotic thrombocytopenic purpura. Current opinion in hematology, 15(5), pp. 445-50. Hagerstown, Md.: Wolters Kluwer Lippincott Williams & Wilkins 10.1097/MOH.0b013e328309ec62

Rüfer, Axel; Brodmann, Doreen; Gregor, Michael; Kremer Hovinga, Johanna A; Lämmle, Bernhard; Wuillemin, Walter A (2007). Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature. Swiss medical weekly, 137(37-38), pp. 518-24. Muttenz: EMH Schweizerischer Ärzteverlag

Swisher, Karen K; Doan, John T; Vesely, Sara K; Kwaan, Hau C; Kim, Benjamin; Laemmle, Bernhard; Kremer Hovinga, Johanna A; George, James N (2007). Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica - the hematology journal, 92(7), pp. 936-43. Pavia: Ferrata-Storti Foundation 10.3324/haematol.10963

Schneppenheim, Reinhard; Kremer Hovinga, Johanna A; Becker, Tim; Budde, Ulrich; Karpman, Diana; Brockhaus, Wolfgang; Hrachovinová, Ingrid; Korczowski, Bartosz; Oyen, Florian; Rittich, Simon; von Rosen, Johannes; Tjønnfjord, Geir E; Pimanda, John E; Wienker, Thomas F; Lämmle, Bernhard (2006). A common origin of the 4143insA ADAMTS13 mutation. Thrombosis and haemostasis, 96(1), pp. 3-6. Stuttgart: Schattauer 10.1160/TH05-12-0817

This list was generated on Fri Mar 29 08:49:45 2024 CET.
Provide Feedback